Fig. 1From: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysisRelative risk for live birth rate with biosimilar preparations of follitropin alfa versus the reference productBack to article page